Guardion Health Sciences, Inc

(NASDAQ:GHSI)

Latest On Guardion Health Sciences, Inc (GHSI):

Date/Time Type Description Signal Details
2023-05-30 15:17 ESTNewsGuardion Health Sciences appoints president and CEON/A
2023-05-15 10:26 ESTNewsGuardion Health Sciences GAAP EPS of $0.42, revenue of $3.19MN/A
2023-04-17 21:56 ESTNewsGuardion Health Sciences GAAP EPS of -$14.15, revenue of $11.05MN/A
2023-01-25 04:00 ESTNewsGuardion Health Sciences regains compliance with NasdaqN/A
2022-11-14 09:16 ESTNewsGuardion Health Sciences GAAP EPS of -$0.11 misses by $0.08, revenue of $2.66M misses by $0.89MN/A
2022-08-11 09:58 ESTNewsGuardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67MN/A
2022-06-01 15:20 ESTNewsGuardion Health Sciences enters agreement with OmegaQuant Laboratories to provide support servicesN/A
2022-05-12 17:55 ESTNewsGuardion Health Sciences GAAP EPS of -$0.07 beats by $0.01, revenue of $2.38M beats by $0.17MN/A
2022-04-01 23:18 ESTNewsGuardion Health Sciences GAAP EPS of -$1.04 beats by $0.18, revenue of $7.23M beats by $0.03MN/A
2022-02-18 14:52 ESTNewsGuardion Health Sciences stock falls ~45% pre-market on pricing $11.1M equity offeringN/A
2022-02-17 17:27 ESTNewsGuardion Health Sciences plunges 20% on launching stock offeringN/A
2022-01-24 21:06 ESTNewsGuardion Health Sciences launches online store for ViactivN/A
2021-07-21 10:24 ESTNewsGuardion Health closes Activ Nutritional acquisitionN/A
2021-07-21 10:23 ESTNewsGuardion Health Sciences names Craig Sheehan as chief commercial officerN/A
2021-07-21 10:12 ESTNewsGuardion Health set to join Russell 3000 IndexN/A
2021-05-03 23:16 ESTNewsGuardion Health initiates GlaucoCetin glaucoma trialN/A
2021-03-26 09:31 ESTNewsGuardion Health Sciences reports Q4 resultsN/A
2021-03-01 23:51 ESTStock SplitA stock split has occured on Mar 1, 2021 with a split factor of 1:6.Neutral
2021-02-26 19:54 ESTNewsGuardion Health Sciences plummets 24% on 1-for-6 reverse splitN/A
2021-01-20 18:23 ESTNewsGuardion Health’s Malaysian licensee receives approval for health supplementN/A
2020-12-29 01:25 ESTNewsGuardion Health names industry veteran Bret Scholtes as new president and CEON/A
2020-11-26 20:08 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 04:07 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 00:11 ESTNewsGuardion Health Sciences reports Q3 resultsN/A
2020-11-07 15:56 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 12:52 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:59 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 16:46 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 08:56 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 18:40 ESTNewsGuardion Health Sciences, Inc.'s (GHSI) CEO Dr. David Evans on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-12 16:31 ESTNewsGuardion Health Sciences reports Q2 resultsN/A
2020-07-31 01:06 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:09 ESTFinancialsCompany financials have been released.Neutral
2020-07-15 14:35 ESTNewsVectorVision receives Korean approval for CSV-2000 trademarkN/A
2020-07-09 08:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:09 ESTNewsGuardion Health Sciences fulfills $875K order of immuno-supportive formulaN/A
2020-06-26 08:49 ESTFinancialsCompany financials have been released.Neutral
2020-06-16 02:02 ESTNewsGuardion Health Sciences names Dr. David Evans as interim President and CEON/A
2020-06-12 04:52 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 04:56 ESTFinancialsCompany financials have been released.Neutral
2020-05-20 12:54 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 22:14 ESTNewsGuardion Health Sciences reports Q1 resultsN/A
2020-05-06 04:59 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:57 ESTFinancialsCompany financials have been released.Neutral
2020-04-11 17:08 ESTNewsGuardion Health Sciences reports FY resultsN/A
2020-04-03 00:48 ESTFinancialsCompany financials have been released.Neutral
2020-04-02 04:40 ESTFinancialsCompany financials have been released.Neutral
2020-04-02 00:40 ESTFinancialsCompany financials have been released.Neutral
2020-03-22 00:46 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:55 ESTFinancialsCompany financials have been released.Neutral

About Guardion Health Sciences, Inc (GHSI):

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Medical Devices. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Medical Devices segment offers VectorVision, which develops, manufactures, and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing; CSV-1000, an instrument for contrast sensitivity, glare sensitivity, low contrast acuity, and early treatment diabetic retinopathy; CSV-2000, a digital standardized contrast sensitivity testing device; and MapcatSF, a medical device that measures the macular pigment optical density. The company distributes its products through sales force, as well as through its guardionhealth.com Website. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

GHSI Quotes by TradingView

See Advanced Chart

General

  • Name Guardion Health Sciences, Inc
  • Symbol GHSI
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 21
  • Last Split Factor1:6
  • Last Split Date2021-03-01
  • Fiscal Year EndDecember
  • IPO Date2019-04-05
  • Gic SectorConsumer Staples
  • Gic GroupHousehold & Personal Products
  • Gic IndustryPersonal Products
  • Web URLhttp://www.guardionhealth.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 19.64
  • Price/Book (Most Recent Quarter) 6.48
  • Enterprise Value Revenue 29.44
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Operating Margin -420%
  • Return on Assets -48%
  • Return on Equity -99%
  • Revenue 1.93 million
  • Earnings Per Share -$0.39
  • Revenue Per Share $0.15
  • Gross Profit 561622
  • Quarterly Earnings Growth 57.1%
View More

Highlights

  • Market Capitalization 65.59 million
  • EBITDA -6209809
  • PE Ratio 65.01
  • Book Value Per Share $0.73
View More

Share Statistics

  • Shares Outstanding 24.39 million
  • Shares Float 13.52 million
  • % Held by Insiders 389%
  • % Held by Institutions 5.04%
  • Shares Short 446349
  • Shares Short Prior Month 4.87 million
  • Short Ratio 0.01
View More

Technicals

  • 52 Week High $8.4
  • 52 Week Low $0.99
  • 50 Day Moving Average 4.38
  • 200 Day Moving Average 2.49
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Guardion Health Sciences, Inc (GHSI) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Guardion Health Sciences, Inc (GHSI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$N/A-$0.02
2020-06-302020-09-30$1.19 million-$0.15
2020-03-312020-06-30$245723-$0.05
2019-12-312020-03-31$N/A-$0.18
2019-09-302019-12-31$161162-$0.37
2019-06-302019-09-30$260970-$0.40
2019-03-312019-06-30$242538-$0.81$0.00
2018-12-312019-03-31$234106-$0.40$0.00
2018-09-302018-12-31$294230-$0.44$0.00
2018-06-302018-09-30$220778-$0.64$0.00
2018-03-312018-06-30$193040-$0.54$0.00
2017-12-312018-03-31-$0.69$0.00
2017-09-302017-12-31-$0.89$0.00
2017-06-302017-09-30-$0.89$0.00
2017-03-312017-06-30-$0.45$0.00
2016-12-312017-03-31-$0.36$0.00
2016-09-302016-12-31-$1.49$0.00
2016-06-302016-09-30-$0.75$0.00
2016-03-312016-06-30-$0.78$0.00
2015-12-312016-03-31-$0.54$0.00
2015-09-302015-12-31-$0.69$0.00
2015-06-302015-09-30-$1.59$0.00
2015-03-312015-06-30-$2.40$0.00
2014-12-312015-03-31-$2.40$0.00
2014-09-302014-12-31-$0.39$0.00

Guardion Health Sciences, Inc (GHSI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A 44581 31188 N/A 31897
Income Before Tax N/A -707160 -2.35 million N/A -2.39 million
Selling General Administrative N/A 1.18 million 2.44 million N/A 2.47 million
Gross Profit N/A 546330 136615 N/A 90163
Ebit N/A -643521 -2.28 million N/A -2.41 million
Operating Income N/A -677278 -2.34 million N/A -2.41 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A 1.19 million 245723 N/A 161162
Cost of Revenue N/A 644579 109108 N/A 70999
Total Other Income Expense Net N/A -28092 -8944 N/A 27117
Net Income From Continuing Operations N/A -707160 -2.35 million N/A -2.39 million
Net Income Applicable to Common Shares -2.14 million -707160 N/A -4.06 million -2.39 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -40733 N/A N/A
Change to Liabilities 244103 83403 N/A -89683 -80875
Total Cash Flow from Investing Activities 6000 N/A N/A -7971 -104171
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A 998640 3.55 million N/A 4.99 million
Change to Operating Activities -56969 63001 N/A -130293 -93721
Change in Cash N/A -1.29 million 1.77 million N/A 3.19 million
Total Cash from Operating Activities -1.82 million -2.29 million -1.74 million -1.84 million -1.7 million
Depreciation N/A 61849 61097 N/A 104336
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A -475967 -131195 N/A -1669
Change to Account Receivables N/A -3098 47255 N/A 13993
Other Cash Flow from Financing Activities N/A N/A N/A N/A 19000
Change to Net Income 136556 -1.31 million N/A 2.16 million 747958
Capital Expenditures N/A N/A 40733 N/A 104171
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A 1.34 million 1.54 million N/A 906214
Total Stockholder Equity N/A 12.7 million 13.74 million N/A 8.05 million
Other Current Liabilities 237727 19411 22267 N/A 47118
Total Assets N/A 14.03 million 15.28 million N/A 8.96 million
Common Stock 88327 88310 N/A 74983 50483
Other Current Assets N/A 24500 N/A N/A N/A
Retained Earnings -50.71 million -48.57 million -47.86 million -45.51 million -41.46 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 11751 11751 N/A 11751 11751
Cash N/A 11.6 million 12.89 million N/A 5.55 million
Total Current Liabilities 1.16 million 983236 1.15 million N/A 458922
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 763277 800921 N/A 947352 953022
Total Current Assets 11.33 million 13.17 million 14.3 million N/A 6.13 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 10.64 million 12.65 million N/A 11.98 million 6.19 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory 1.28 million 1.24 million 759085 N/A 320355
Accounts Payable 576890 332787 249383 N/A 218815

Guardion Health Sciences, Inc (GHSI) Chart:

Guardion Health Sciences, Inc (GHSI) News:

Below you will find a list of latest news for Guardion Health Sciences, Inc (GHSI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Guardion Health Sciences, Inc (GHSI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest GHSI Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST91$0.1432
Jun 13, 2022 7:59 PM EST100$0.1432
Jun 13, 2022 7:59 PM EST83$0.1432
Jun 13, 2022 7:59 PM EST17$0.1432
Jun 13, 2022 7:59 PM EST75$0.1432

Guardion Health Sciences, Inc (GHSI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220012488/0001493152-20-012488-index.htm
2018-10-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000018033142/0000000000-18-033142-index.htm
2019-07-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000019010908/0000000000-19-010908-index.htm
2019-07-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000019011541/0000000000-19-011541-index.htm
2019-10-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000019014614/0000000000-19-014614-index.htm
2019-10-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000019014892/0000000000-19-014892-index.htm
2019-11-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000019015169/0000000000-19-015169-index.htm
2020-09-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1642375/000000000020008908/0000000000-20-008908-index.htm
2019-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642375/000090266419004175/0000902664-19-004175-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642375/000090266420000480/0000902664-20-000480-index.htm
2018-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000114420418027703/0001144204-18-027703-index.htm
2018-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420418032906/0001144204-18-032906-index.htm
2018-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000114420418043655/0001144204-18-043655-index.htm
2018-10-04DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1642375/000114420418052419/0001144204-18-052419-index.htm
2018-10-10PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1642375/000114420418053196/0001144204-18-053196-index.htm
2018-10-15DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1642375/000114420418053797/0001144204-18-053797-index.htm
2018-10-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1642375/000114420418054649/0001144204-18-054649-index.htm
2018-10-31S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420418056447/0001144204-18-056447-index.htm
2018-10-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000114420418056449/0001144204-18-056449-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000114420418059482/0001144204-18-059482-index.htm
2018-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420418061217/0001144204-18-061217-index.htm
2018-11-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420418061218/0001144204-18-061218-index.htm
2018-11-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420418061313/0001144204-18-061313-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420418062681/0001144204-18-062681-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420418066352/0001144204-18-066352-index.htm
2019-01-03DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419000215/0001144204-19-000215-index.htm
2019-01-07S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420419000760/0001144204-19-000760-index.htm
2019-01-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420419001194/0001144204-19-001194-index.htm
2019-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420419001719/0001144204-19-001719-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420419004494/0001144204-19-004494-index.htm
2019-02-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1642375/000114420419007374/0001144204-19-007374-index.htm
2019-02-25S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420419009713/0001144204-19-009713-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420419015295/0001144204-19-015295-index.htm
2019-03-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420419015300/0001144204-19-015300-index.htm
2019-03-27S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000114420419016341/0001144204-19-016341-index.htm
2019-04-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000114420419017909/0001144204-19-017909-index.htm
2019-04-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000114420419017911/0001144204-19-017911-index.htm
2019-04-04DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419018155/0001144204-19-018155-index.htm
2019-04-048-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1642375/000114420419018156/0001144204-19-018156-index.htm
2019-04-08424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1642375/000114420419018625/0001144204-19-018625-index.htm
2019-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000114420419018895/0001144204-19-018895-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419019054/0001144204-19-019054-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419019058/0001144204-19-019058-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419019060/0001144204-19-019060-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419019063/0001144204-19-019063-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419020084/0001144204-19-020084-index.htm
2019-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000114420419020086/0001144204-19-020086-index.htm
2019-04-04CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1642375/000135445719000190/0001354457-19-000190-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000149315219006782/0001493152-19-006782-index.htm
2019-05-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219007833/0001493152-19-007833-index.htm
2019-07-03S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315219010273/0001493152-19-010273-index.htm
2019-07-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219010445/0001493152-19-010445-index.htm
2019-07-10RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219010479/0001493152-19-010479-index.htm
2019-07-10RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219010480/0001493152-19-010480-index.htm
2019-07-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315219010511/0001493152-19-010511-index.htm
2019-07-15424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1642375/000149315219010637/0001493152-19-010637-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219010660/0001493152-19-010660-index.htm
2019-07-19DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1642375/000149315219010890/0001493152-19-010890-index.htm
2019-07-19DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1642375/000149315219010891/0001493152-19-010891-index.htm
2019-08-07S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315219011754/0001493152-19-011754-index.htm
2019-08-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219011755/0001493152-19-011755-index.htm
2019-08-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219011759/0001493152-19-011759-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000149315219012029/0001493152-19-012029-index.htm
2019-08-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315219012031/0001493152-19-012031-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219012077/0001493152-19-012077-index.htm
2019-08-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315219012081/0001493152-19-012081-index.htm
2019-08-15424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1642375/000149315219012700/0001493152-19-012700-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219013003/0001493152-19-013003-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219013279/0001493152-19-013279-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219014497/0001493152-19-014497-index.htm
2019-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219014610/0001493152-19-014610-index.htm
2019-10-08DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015178/0001493152-19-015178-index.htm
2019-10-07DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015180/0001493152-19-015180-index.htm
2019-10-18PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015704/0001493152-19-015704-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015826/0001493152-19-015826-index.htm
2019-10-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015989/0001493152-19-015989-index.htm
2019-10-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015990/0001493152-19-015990-index.htm
2019-10-25S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315219015991/0001493152-19-015991-index.htm
2019-10-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219015992/0001493152-19-015992-index.htm
2019-10-29424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1642375/000149315219016106/0001493152-19-016106-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219016276/0001493152-19-016276-index.htm
2019-11-04PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219016411/0001493152-19-016411-index.htm
2019-11-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315219016412/0001493152-19-016412-index.htm
2019-11-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219016562/0001493152-19-016562-index.htm
2019-11-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1642375/000149315219016649/0001493152-19-016649-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000149315219017065/0001493152-19-017065-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219018979/0001493152-19-018979-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315219019872/0001493152-19-019872-index.htm
2019-12-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219019873/0001493152-19-019873-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315219019875/0001493152-19-019875-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220003511/0001493152-20-003511-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220004363/0001493152-20-004363-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1642375/000149315220005000/0001493152-20-005000-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220005044/0001493152-20-005044-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220005630/0001493152-20-005630-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220006855/0001493152-20-006855-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220008586/0001493152-20-008586-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000149315220008601/0001493152-20-008601-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220011253/0001493152-20-011253-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220012483/0001493152-20-012483-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220012484/0001493152-20-012484-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220012485/0001493152-20-012485-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220012487/0001493152-20-012487-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220012488/0001493152-20-012488-index.htm
2020-07-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220013801/0001493152-20-013801-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220013802/0001493152-20-013802-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220013878/0001493152-20-013878-index.htm
2020-08-03PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220014429/0001493152-20-014429-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1642375/000149315220015346/0001493152-20-015346-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220015347/0001493152-20-015347-index.htm
2020-08-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220016366/0001493152-20-016366-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220016368/0001493152-20-016368-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220016370/0001493152-20-016370-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220016372/0001493152-20-016372-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220017330/0001493152-20-017330-index.htm
2020-09-08DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1642375/000149315220017434/0001493152-20-017434-index.htm
2020-09-18S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315220018011/0001493152-20-018011-index.htm
2020-09-22S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1642375/000149315220018176/0001493152-20-018176-index.htm
2020-09-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1642375/000149315220018224/0001493152-20-018224-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220019088/0001493152-20-019088-index.htm
2020-10-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1642375/000149315220019965/0001493152-20-019965-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1642375/000149315220020352/0001493152-20-020352-index.htm
2019-11-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642375/000153561019000099/0001535610-19-000099-index.htm
2020-01-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1642375/000153561020000034/0001535610-20-000034-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1642375/000171737019000002/0001717370-19-000002-index.htm
2019-04-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642375/999999999519000600/9999999995-19-000600-index.htm
2019-07-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642375/999999999519001586/9999999995-19-001586-index.htm
2019-08-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642375/999999999519001869/9999999995-19-001869-index.htm
2019-10-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642375/999999999519002412/9999999995-19-002412-index.htm
2020-09-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1642375/999999999520002578/9999999995-20-002578-index.htm

Guardion Health Sciences, Inc (GHSI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Guardion Health Sciences, Inc (GHSI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 389%
Institutional Ownership: 504%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-04-09MICHAEL FAVISHChief Executive OfficerBuy1,000.004.004,000.001,000.00https://www.sec.gov/Archives/edgar/data/1642375/000114420419019054/0001144204-19-019054-index.htm
2019-04-09Donald A GaglianoDirectorBuy1,250.004.005,000.00136,000.00https://www.sec.gov/Archives/edgar/data/1642375/000114420419020086/0001144204-19-020086-index.htm
2019-04-09Donald A GaglianoDirectorBuy250.003.55887.50136,250.00https://www.sec.gov/Archives/edgar/data/1642375/000114420419020086/0001144204-19-020086-index.htm
2019-04-09David W EvansChief Scientific OfficerBuy6,500.004.0026,000.001,502,500.00https://www.sec.gov/Archives/edgar/data/1642375/000114420419019060/0001144204-19-019060-index.htm
2019-08-15David W EvansChief Science OfficerBuy20,000.000.448,800.001,522,500.00https://www.sec.gov/Archives/edgar/data/1642375/000149315219013279/0001493152-19-013279-index.htm
2019-08-21David W EvansChief Science OfficerBuy20,000.001,542,500.00https://www.sec.gov/Archives/edgar/data/1642375/000149315219013279/0001493152-19-013279-index.htm
2019-10-30David W EvansChief Science OfficerBuy2,000.000.33664.001,544,500.00https://www.sec.gov/Archives/edgar/data/1642375/000171737019000002/0001717370-19-000002-index.htm
2019-04-08Mark GoldstoneDirectorBuy300.003.531,059.96525,300.00https://www.sec.gov/Archives/edgar/data/1642375/000114420419019063/0001144204-19-019063-index.htm
2019-04-09ROBERT N WEINGARTENDirectorBuy2,500.004.0010,000.00652,500.00https://www.sec.gov/Archives/edgar/data/1642375/000114420419019058/0001144204-19-019058-index.htm